Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic

Area of Science:

• Immunology
• Cancer Biology
• Cellular Biology

Background:

• Myeloid-derived suppressor cells (MDSC) are key regulators of immune responses in cancer.
• MDSCs are pathologically activated neutrophils and monocytes with unique features.
• Their association with poor clinical outcomes makes them attractive therapeutic targets.

Purpose of the Study:

• To discuss the mechanisms regulating MDSC development and fate.
• To highlight recent research advances for therapeutic regulation of MDSCs.
• To address the challenges in developing selective therapies targeting MDSCs.

Main Methods:

• Review of existing literature on MDSC biology.
• Analysis of mechanisms controlling MDSC development and function.
• Examination of therapeutic strategies and challenges.

Main Results:

• MDSCs exhibit distinct biological characteristics and potent immunosuppressive functions.
• MDSC biology is complex, posing challenges for targeted therapy development.
• Recent advances offer potential avenues for therapeutic intervention.

Conclusions:

• MDSCs are significant targets in cancer therapy due to their immunosuppressive role.
• Overcoming the complexity of MDSC biology is crucial for effective therapeutic targeting.
• Further research into MDSC regulation can lead to novel cancer treatment strategies.